Telehealth company Hims & Hers to buy U.K.'s Honest Health
Telehealth company Hims & Hers Health Inc. (HIMS) said late Monday it has agreed to buy London-based health platform Honest Health for an undisclosed amount. Honest Health offers hair loss-related products, including access to compounded products. "The proposed transaction provides Hims & Hers with best-in-class operational capability and infrastructure to support the beginnings of the company's long-term plans for expansion" across the U.K. and western Europe, Hims and Hers said in a statement. The deal is expected to close in the second fiscal quarter of this year, the company said. Shares of Hims and Hers fell 0.6% in the extended session Monday after ending the regular trading day up 5.7%. The stock began trading in January after a merger with a blank-check company.
-Claudia Assis; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
June 14, 2021 17:50 ET (21:50 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.